Ulrike Walther‐Louvier

Development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies

Karim Wahbi, Rabah Ben Yaou, Estelle Gandjbakhch et al. · Circulation · 2019 · 260 citations · Full text

Medicine, Cardiology, Internal Medicine +15

Effects of nusinersen after one year of treatment in 123 children with SMA type 1 or 2: a French real-life observational study

Frédérique Audic, Marta Gómez García de la Banda, Delphine Bernoux et al. · Orphanet Journal of Rare Diseases · 2020 · 101 citations · Full text

Medicine, Neurology, Pediatrics +17

A large multicenter study of pediatric myotonic dystrophy type 1 for evidence-based management

Emmanuelle Lagrue, Céline Dogan, Marie De Antonio et al. · Neurology · 2019 · 73 citations

Medicine, Child Health, Pediatrics +9

Association between prophylactic angiotensin-converting enzyme inhibitors and overall survival in Duchenne muscular dystrophy—analysis of registry data

Raphaël Porcher, Isabelle Desguerre, Helge Amthor et al. · European Heart Journal · 2021 · 50 citations · Full text

Medicine, Cardiology, Pharmacology +16

A Reliable Targeted Next-Generation Sequencing Strategy for Diagnosis of Myopathies and Muscular Dystrophies, Especially for the Giant Titin and Nebulin Genes

Reda Zenagui, Delphine Lacourt, Henri Pégeot et al. · Journal of Molecular Diagnostics · 2018 · 39 citations · Full text

Life Sciences, Genetics, Molecular Genetics +11